Apollo Endosurgery ROA 2006-2018 | APEN
Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years.
| Apollo Endosurgery Annual ROA - Return on Assets | |
|---|---|
| 2017 | -25.03 |
| 2016 | -40.31 |
| 2015 | -26.08 |
| 2014 | -78.99 |
| 2013 | -41.89 |
| 2012 | -10.13 |
| 2011 | -17.36 |
| 2010 | 0.00 |
| 2009 | 0.00 |
| 2008 | -121.66 |
| 2007 | -174.45 |
| 2006 | -238.30 |
| 2005 | -46.97 |
| Apollo Endosurgery Quarterly ROA - Return on Assets | |
|---|---|
| Q2 2018 | -8.64 |
| Q1 2018 | -8.08 |
| Q4 2017 | -6.71 |
| Q3 2017 | -4.30 |
| Q2 2017 | -7.96 |
| Q1 2017 | -9.28 |
| Q4 2016 | -19.30 |
| Q3 2016 | -146.57 |
| Q2 2016 | -134.63 |
| Q1 2016 | -62.11 |
| Q4 2015 | -18.79 |
| Q3 2015 | -15.57 |
| Q2 2015 | -17.29 |
| Q1 2015 | -16.20 |
| Q4 2014 | -30.34 |
| Q3 2014 | -11.88 |
| Q2 2014 | -20.24 |
| Q1 2014 | -15.26 |
| Q4 2013 | -8.96 |
| Q3 2013 | -14.08 |
| Q2 2013 | -6.84 |
| Q1 2013 | -5.42 |
| Q4 2012 | -6.07 |
| Q3 2012 | -5.87 |
| Q2 2012 | -3.08 |
| Q1 2012 | 2.77 |
| Q4 2011 | -22.12 |
| Q3 2011 | 5.64 |
| Q2 2011 | 0.00 |
| Q1 2011 | 0.00 |
| Q4 2010 | 0.00 |
| Q3 2010 | 0.00 |
| Q2 2010 | 0.00 |
| Q1 2010 | 0.00 |
| Q4 2009 | 0.00 |
| Q3 2009 | 89.10 |
| Q2 2009 | -55.94 |
| Q1 2009 | 7.09 |
| Q4 2008 | -18.95 |
| Q3 2008 | -30.06 |
| Q2 2008 | -76.27 |
| Q1 2008 | -77.53 |
| Q4 2007 | -49.36 |
| Q3 2007 | -38.90 |
| Q2 2007 | -22.75 |
| Q1 2007 | -177.78 |
| Q4 2006 | -65.96 |
| Q3 2006 | -34.32 |
| Q2 2006 | -29.62 |
| Q1 2006 | -22.04 |
| Q4 2005 | -46.90 |
| Q3 2005 | -100.00 |
| Q2 2005 | -50.00 |
| Q1 2005 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.168B | $0.064B |
| Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $92.643B | 22.22 |
| Intuitive Surgical (ISRG) | United States | $59.708B | 56.99 |
| Fresenius Medical Care (FMS) | Germany | $29.726B | 21.00 |
| Edwards Lifesciences (EW) | United States | $29.266B | 32.97 |
| IDEXX Laboratories (IDXX) | United States | $21.085B | 64.08 |
| ABIOMED (ABMD) | United States | $16.103B | 131.92 |
| DexCom (DXCM) | United States | $11.571B | 0.00 |
| Teleflex (TFX) | United States | $10.906B | 25.94 |
| Hologic (HOLX) | United States | $10.430B | 17.75 |
| Varian Medical Systems (VAR) | United States | $10.181B | 25.62 |
| STERIS (STE) | United Kingdom | $9.648B | 26.54 |
| LivaNova (LIVN) | United Kingdom | $5.998B | 35.78 |
| Masimo (MASI) | United States | $5.894B | 39.24 |
| Globus Medical (GMED) | United States | $5.127B | 34.10 |
| Integra LifeSciences Holdings (IART) | United States | $5.020B | 25.98 |
| Inogen (INGN) | United States | $4.967B | 131.44 |
| Penumbra (PEN) | United States | $4.321B | 392.81 |
| Cantel Medical (CMD) | United States | $4.015B | 41.85 |
| Opko Health (OPK) | United States | $3.140B | 0.00 |
| Halyard Health (AVNS) | United States | $3.081B | 25.35 |
| Wright Medical Group (WMGI) | Netherlands | $2.934B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.287B | 20.71 |
| Nevro (NVRO) | United States | $1.867B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.802B | 0.00 |
| AxoGen (AXGN) | United States | $1.447B | 0.00 |
| Glaukos (GKOS) | United States | $1.402B | 803.40 |
| Natus Medical (BABY) | United States | $1.219B | 25.85 |
| Luminex (LMNX) | United States | $1.195B | 35.25 |
| Accelerate Diagnostics (AXDX) | United States | $1.194B | 0.00 |
| CryoLife (CRY) | United States | $1.186B | 104.03 |
| Mazor Robotics (MZOR) | Israel | $1.173B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.103B | 188.09 |
| Orthofix (OFIX) | United States | $1.017B | 30.99 |
| K2Ms (KTWO) | United States | $0.891B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.803B | 29.81 |
| Intersect ENT (XENT) | United States | $0.799B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.781B | 48.33 |
| ViewRay (VRAY) | United States | $0.751B | 0.00 |
| Sientra (SIEN) | United States | $0.581B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.553B | 0.00 |
| Neuronetics (STIM) | United States | $0.550B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.416B | 0.00 |
| Veracyte (VCYT) | United States | $0.403B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.391B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.388B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.363B | 0.00 |
| Accuray (ARAY) | United States | $0.332B | 0.00 |
| IRadimed (IRMD) | United States | $0.315B | 113.27 |
| Nuvectra (NVTR) | United States | $0.297B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.288B | 56.88 |
| T2 Biosystems (TTOO) | United States | $0.282B | 0.00 |
| Fluidigm (FLDM) | United States | $0.266B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.252B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.235B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.210B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.165B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.151B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.103B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.099B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.094B | 0.00 |
| EDAP TMS (EDAP) | France | $0.090B | 0.00 |
| Invuity (IVTY) | United States | $0.088B | 0.00 |
| Neovasc (NVCN) | Canada | $0.064B | 0.00 |
| ConforMIS (CFMS) | United States | $0.057B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.053B | 0.00 |
| Vermillion (VRML) | United States | $0.041B | 0.00 |
| PAVmed (PAVM) | United States | $0.038B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.034B | 0.00 |
| Presbia (LENS) | Ireland | $0.033B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.030B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.028B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.025B | 0.00 |
| Dynatronics (DYNT) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.022B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.019B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.010B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.006B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| Amedica (AMDA) | United States | $0.002B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
